Skip to main content
. 2018 Jul 10;29(2):1032–1038. doi: 10.1007/s00330-018-5618-5

Fig. 4.

Fig. 4

Kaplan-Meier survival curve demonstrating the association between target tumour enhancement at 20-min delayed phase (Target TuEn20) and overall survival in patients with colorectal liver metastases who had received preoperative gadoxetate-enhanced MRI prior to hepatectomy (n = 64) (p = 0.011)